Last reviewed · How we verify

NCT05013021: BénéfiSIT

Sprint Interval Training on the Endurance, Strength and Velocity Capacities of Healthy Sedentary Subjects

Completed NA Last updated 19 July 2023
What this trial tests

NA trial testing Sprint Interval Training in Sedentary Behavior in 23 participants. Completed in 29 March 2023.

Timeline
27 September 2021
Primary endpoint
8 March 2023
29 March 2023

Quick facts

Lead sponsorCentre Hospitalier Universitaire de Saint Etienne
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment23
Start date27 September 2021
Primary completion8 March 2023
Estimated completion29 March 2023
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Universitaire de Saint Etienne

Who can join

Adults 18 to 40, any sex, with Sedentary Behavior. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present study aims to analyse first, the acute effects generated by a single bout of Sprint Interval Training (SIT) and, secondly, the effects of a long-term intervention on sedentary participants.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Sprint Interval Training

Trials testing the same drug.

Other recruiting trials for Sedentary Behavior

Currently open trials in the same condition.

Other Centre Hospitalier Universitaire de Saint Etienne trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05013021.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing